Pine Pharmaceuticals, LLC recalls Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in indiv
Recalled April 19, 2023 · FDA recall D-0531-2023 · Pine Pharmaceuticals
Hazard
Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect. · FDA Class III
Units
932 syringes
Sold at
Nationwide in the USA
Description
Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
Product
Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes (primary packaging). Repackaged by Pine Pharmaceuticals, Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150, Office Use Only, Not for Resale. Secondary packaging consists of a coated cardboard box, with order-specific label indicating lot number housed within order/container. NDC # 69194-0458-1
Manufacturer(s)
Pine Pharmaceuticals, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →